Pharmacogenomic tests for insurers

Reduce disability-related costs through pharmacogenomics and improve the health and well-being of your policyholders

Pharmacogenomic testing (PGx) is now a key tool for insurance companies. Its aim is to establish the compatibility of a drug with a patient’s metabolism, based on a DNA test. With PGx testing, healthcare professionals can determine whether a drug has an increased risk of being ineffective or causing significant side effects in a particular patient. Thus, these tests reduce trial-and-error periods by helping healthcare professionals find the right treatment for a patient’s specific needs faster, based on their genetic profile.

The benefits of pharmacogenomic testing for insurers

Reducing claims and shortening disability periods

With the right treatment for mental health disorders or pain management, your policyholders can stay on the job or shorten their period of disability.

Faster treatment

By guiding the medication choices of policyholders based on their genetics, you help reduce trial-and-errors, as well as the duration of absences and related costs.

Reducing the costs of ineffective medications

Biron Genetic’s PGx test can help guide medication choices and thus reduce treatment costs for insurers.

Improving the well-being of policyholders

Ineffective treatment can greatly impact your clients’ daily lives and weight on their mental and physical health. By tailoring the treatment to their DNA, their well-being can be significantly improved.

Do insurers have access to the results of the reports?

No. Client results are never shared with a third party without their consent. If you wish to access them, the patient’s consent must first be obtained.

How is the data secured?

Genetic data is encrypted on multiple levels and stored on Canadian servers that meet the highest security standards. Our SOC2 Type 2 certification is tested annually by an external auditor to ensure the robustness of our systems. Biron Genetics protects access to genetic data by letting each patient control who can access their information.

For how long are the results valid?

Since the genetic code does not change, the results will be the same whether the test is taken at the age of 7 or 70. However, science evolves, and it is possible that the interpretation of the results will change over time. The report will be updated periodically at no additional charge to ensure that the client and their healthcare professional have the most current and scientifically sound information possible. Additional charges may apply if further genetic testing is required.

Pharmacogenomic tests for insurers

What is a pharmacogenomic or PGx testing?

Mental health—a major issue with disability and presenteeism

The benefits of pharmacogenomic testing for insurers

Reducing claims and shortening disability periods

Faster treatment

Reducing the costs of ineffective medications

Improving the well-being of policyholders

When should insurers use pharmacogenomic testing?

The benefits of pharmacogenomic testing are measurable

The benefits of the Biron pharmacogenomic (PGx) tests

Support for plan managers

A dedicated portal for your policyholders

Report covering 145 medications used to treat mental health and pain problems

Rapid results within 10 days

Data security and confidentiality

Accreditations and certifications

Our laboratory is CAP certified – College of American Pathologists

Our systems are Soc2 Type II accredited